NCT00661154View on ClinicalTrials.gov

Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2010

Conditions
Colorectal NeoplasmsColon CancerRectal CancerAnal Cancer
Interventions
DRUG

Bevacizumab

2-12microCi IV injection

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Stanford University

OTHER